Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 02, 2022

BUY
$32.4 - $68.18 $286,610 - $603,120
8,846 New
8,846 $602,000
Q1 2021

May 05, 2021

SELL
$38.94 - $50.85 $287,922 - $375,984
-7,394 Closed
0 $0
Q4 2020

Feb 04, 2021

SELL
$37.65 - $63.77 $863,126 - $1.46 Million
-22,925 Reduced 75.61%
7,394 $320,000
Q3 2020

Nov 02, 2020

SELL
$52.76 - $74.49 $7.09 Million - $10 Million
-134,448 Reduced 81.6%
30,319 $1.67 Million
Q2 2020

Aug 05, 2020

BUY
$48.73 - $81.82 $7.21 Million - $12.1 Million
148,038 Added 884.92%
164,767 $10.4 Million
Q1 2020

May 04, 2020

BUY
$41.72 - $87.2 $27,702 - $57,900
664 Added 4.13%
16,729 $855,000
Q2 2019

Jul 29, 2019

SELL
$52.6 - $63.29 $472,874 - $568,977
-8,990 Reduced 35.88%
16,065 $845,000
Q1 2019

Apr 25, 2019

SELL
$39.99 - $53.48 $3,599 - $4,813
-90 Reduced 0.36%
25,055 $1.33 Million
Q4 2018

Feb 11, 2019

SELL
$31.54 - $46.67 $257,208 - $380,593
-8,155 Reduced 24.49%
25,145 $1.03 Million
Q3 2018

Nov 05, 2018

SELL
$38.0 - $51.1 $1.48 Million - $1.99 Million
-39,000 Reduced 53.94%
33,300 $1.27 Million
Q2 2018

Jul 31, 2018

BUY
$38.7 - $50.15 $2.53 Million - $3.28 Million
65,320 Added 935.82%
72,300 $3.27 Million
Q1 2018

Apr 27, 2018

BUY
$39.6 - $65.9 $276,408 - $459,982
6,980 New
6,980 $337,000

Others Institutions Holding GBT

About Global Blood Therapeutics, Inc.


  • Ticker GBT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,476,200
  • Market Cap $4.62B
  • Description
  • Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...
More about GBT
Track This Portfolio

Track Los Angeles Capital Management LLC Portfolio

Follow Los Angeles Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Los Angeles Capital Management LLC with notifications on news.